The Cigna Group is a global health services company. The Companys portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare.
Company profile
Ticker
CI
Exchange
Website
CEO
David Cordani
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Cigna Corp, Halfmoon Parent, Inc.
SEC CIK
Corporate docs
Subsidiaries
Accredo Health Group, Inc. • Accredo Health, Incorporated • Allegiance Life & Health Insurance Company • American Retirement Life Insurance Company • Ascent Health Services LLC • Bravo Health Mid-Atlantic, Inc. • Bravo Health Pennsylvania, Inc. • Care Continuum, Inc. • CareCore NJ, LLC • Chiro Alliance Corporation ...
CI stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
15 Mar 24
ARS
2023 FY
Annual report to shareholders
15 Mar 24
DEF 14A
Definitive proxy
15 Mar 24
8-K
The Cigna Group Raises Long-Term Growth Target, and Launches New Innovative Solutions at 2024 Investor Day
7 Mar 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
The Cigna Group Announces $3.2 Billion Accelerated Stock Repurchase
15 Feb 24
8-K
Entry into a Material Definitive Agreement
13 Feb 24
8-K
Other Events
7 Feb 24
424B5
Prospectus supplement for primary offering
7 Feb 24
FWP
Free writing prospectus
5 Feb 24
Transcripts
CI
Earnings call transcript
2023 Q4
2 Feb 24
CI
Earnings call transcript
2023 Q3
2 Nov 23
CI
Earnings call transcript
2023 Q2
3 Aug 23
CI
Earnings call transcript
2023 Q1
5 May 23
CI
Earnings call transcript
2022 Q4
3 Feb 23
CI
Earnings call transcript
2022 Q3
3 Nov 22
CI
Earnings call transcript
2022 Q2
4 Aug 22
CI
Earnings call transcript
2022 Q1
6 May 22
CI
Earnings call transcript
2021 Q4
3 Feb 22
CI
Earnings call transcript
2021 Q3
4 Nov 21
Latest ownership filings
4
David Cordani
25 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
144
Notice of proposed sale of securities
22 Mar 24
144
Notice of proposed sale of securities
21 Mar 24
4
David Cordani
14 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
144
Notice of proposed sale of securities
12 Mar 24
4
David Cordani
11 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 8.55 bn | 8.55 bn | 8.55 bn | 8.55 bn | 8.55 bn | 8.55 bn |
Cash burn (monthly) | 363.33 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 2.17 bn | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 6.37 bn | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 17.5 | n/a | n/a | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | David Cordani | Common Stock, $.01 Par Value | Sell | Dispose S | No | Yes | 355.1654 | 31,209 | 11.08 mm | 348,054 |
25 Mar 24 | David Cordani | Common Stock, $.01 Par Value | Option exercise | Acquire M | No | Yes | 139.22 | 31,209 | 4.34 mm | 379,263 |
25 Mar 24 | David Cordani | Employee Stock Option Common Stock, $.01 Par Value | Option exercise | Dispose M | No | Yes | 139.22 | 31,209 | 4.34 mm | 7,761 |
22 Mar 24 | David Cordani | Common Stock, $.01 Par Value | Sell | Dispose S | No | Yes | 355.1092 | 6,338 | 2.25 mm | 348,054 |
22 Mar 24 | David Cordani | Common Stock, $.01 Par Value | Option exercise | Acquire M | No | Yes | 139.22 | 6,338 | 882.38 k | 354,392 |
22 Mar 24 | David Cordani | Employee Stock Option Common Stock, $.01 Par Value | Option exercise | Dispose M | No | Yes | 139.22 | 6,338 | 882.38 k | 38,970 |
21 Mar 24 | David Cordani | Common Stock, $.01 Par Value | Sell | Dispose S | No | Yes | 355.016 | 2,293 | 814.05 k | 348,054 |
21 Mar 24 | David Cordani | Common Stock, $.01 Par Value | Option exercise | Acquire M | No | Yes | 139.22 | 2,293 | 319.23 k | 350,347 |
21 Mar 24 | David Cordani | Employee Stock Option Common Stock, $.01 Par Value | Option exercise | Dispose M | No | Yes | 139.22 | 2,293 | 319.23 k | 45,308 |
14 Mar 24 | David Cordani | Common Stock, $.01 Par Value | Option exercise | Acquire M | No | Yes | 139.22 | 7,616 | 1.06 mm | 348,054 |
News
Peering Into Cigna Group's Recent Short Interest
26 Mar 24
Inconsistent Insurance Coverage For Weight Loss Drugs - Novo Nordisk's GLP-1s Face Hurdles Despite Health Benefits
18 Mar 24
Here's How Much $100 Invested In Cigna Group 20 Years Ago Would Be Worth Today
11 Mar 24
Cantor Fitzgerald Maintains Overweight on Cigna Group, Raises Price Target to $384
8 Mar 24
UBS Maintains Buy on Cigna Group, Raises Price Target to $400
8 Mar 24
Press releases
The Cigna Group Raises Long-Term Growth Target, and Launches New Innovative Solutions at 2024 Investor Day
7 Mar 24
Thinking about trading options or stock in Phunware, Angi, Molson Coors, Cigna, or Dell Technologies?
5 Mar 24
The Cigna Group Announces Appearance at Barclays 26th Annual Global Healthcare Conference
27 Feb 24
High Maximum Benefit Dental Insurance Sales Skyrocket
21 Feb 24
The Cigna Group Announces Pricing Terms of Tender Offers
20 Feb 24